L. M. Makarova

L. M. Makarova

Auto-generated profile, based on publicly available information

L. M. Makarova

Speransky Children’s City Clinical Hospital № 9

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2025 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Closed access
PDF file
HSH. A. Sarkisyan
H. A. Sarkisyan
AKA. P. Khokhlova
A. P. Khokhlova
ASA. B. Smolyannikova
A. B. Smolyannikova
ЕШЕ. И. Шабельникова
Е. И. Шабельникова
OSO. V. Shatokhina
O. V. Shatokhina
ЕСЕ. А. Саркисян
Е. А. Саркисян
Ring chromosome formations are one of the rare genetic anomalies with a prevalence of 1:25,000 — 1:62,000 newborns. Ring chromosomes are formed as a result of sporadic terminal deletions of chromosomal arms, which then “stick together” and form a ring. In 1% of cases, ring chromosomes are inherited from parents. Chromosome 13 ring syndrome is a genetic disorder caused by an anomaly in chromosome 13. This syndrome is rare and is usually associated with a widely varying phenotype (from mild to severe). At the same time, the nature of clinical manifestations is associated with the length of the lost section of the chromosome and, as a result, the number of lost genes. The disease leads to a number of disorders: intrauterine growth retardation, short stature, moderate to severe moderate to severe intellectual disability, microcephaly, facial dysmorphic disorder, limb abnormalities and genital abnormalities. Additional signs have been reported, including behavioral problems, hearing and speech disorders, congenital heart defects, brain malformations, and anal atresia. The main diagnostic method is karyotyping, and the research material can be both amniotic fluid (prenatal diagnosis) and tissues of an already born child (postnatal diagnosis). The article, using a clinical case description as an example, examines the mechanisms of occurrence, main aspects of clinical manifestations, diagnosis, treatment and prognosis in a child with ring chromosome 13 syndrome.

1 January 2024 in Neonatology: News, Opinions, Training
Verified
Journal Article
Open access
MSMoscow Children’s CityClinical Hospital No. 9 named after G.N. Speransky
Moscow Children’s CityClinical Hospital No. 9 named after G.N. Speransky
AMA.I. Makulova
A.I. Makulova
AТA.O. Тoporkova
A.O. Тoporkova
NKN.V. Kholodnova
N.V. Kholodnova
LML.M. Makarova
L.M. Makarova
IAI.I. Afukov
I.I. Afukov
Гемосорбция у новорожденного c ранним неонатальным сепсисом (клинический случай)

16 July 2025 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Closed access
PDF file
VMV. A. Mironova
V. A. Mironova
HSH. A. Sarkisyan
H. A. Sarkisyan
YZYu. V. Zhirkova
Yu. V. Zhirkova
ESE. I. Shabelnikova
E. I. Shabelnikova
AKA. P. Khokhlova
A. P. Khokhlova
ЕСЕ. А. Саркисян
Е. А. Саркисян
Barakat syndrome is a rare autosomal dominant genetic disease characterized by a triad of symptoms: hypoparathyroidism, sensorineural hearing loss and kidney dysplasia. The disease is associated with a mutation in the GATA3 gene located on the short arm of chromosome 10 (10p15), which leads to impaired embryonic development of the parathyroid glands, auditory system and kidneys. The article presents a clinical case of a patient with Barakat syndrome, in whom, in addition to the main clinical manifestations, unilateral ptosis was also detected. After birth, the boy showed signs of acute renal damage and hypocalcemia, which required intensive therapy and correction of electrolyte disorders. The uniqueness of this case lies in the presence of a previously undescribed mutation in the GATA3 gene, as well as in the diagnosis of the disease at the age of 6 months. In order to diagnose Barakat syndrome early, a multidisciplinary approach is important, and timely treatment significantly improves the condition of patients.

27 April 2025 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Closed access
PDF file
AKA. A. Komarova
A. A. Komarova
HSH. A. Sarkisyan
H. A. Sarkisyan
YZY. V. Zhirkova
Y. V. Zhirkova
LVL. D. Vorona
L. D. Vorona
SCS. V. Cherkasova
S. V. Cherkasova
PSP. V. Shumilov
P. V. Shumilov
Hemorrhagic disorder of the newborn (or Vitamin K Deficiency Bleeding, VKDB) is a pathological condition caused by a deficiency of vitamin K, which is necessary for the synthesis of blood clotting factors, in children aged 8 days to 6 months. Vitamin K Deficiency Bleeding manifests as bleeding from various localizations. The late form of disease is typically diagnosed after the first week of life and can present as severe intracranial hemorrhages, which in turn can lead not only to residual neurological symptoms but also to fatal outcomes. This condition is observed in newborns who have not received prophylactic vitamin K administration at the delivery and are exclusively breastfed. This underscores the necessity for prevention, timely diagnosis, and treatment. Diagnosis is based on the medical history, clinical picture, and laboratory blood clotting analyses. The updated clinical recommendations for Vitamin K Deficiency Bleeding prevention have been implemented globally and in Russia, but the concerns of management children with late form of Vitamin K Deficiency Bleeding are still relevant. This article presents three clinical cases of full-term infants with late forms of Vitamin K Deficiency Bleeding. They did not receive prophylactic vitamin K administration and were exclusively breastfed. Special attention is given to the diagnosis and treatment of neurological disorders associated with intracranial hemorrhage, as well as the importance of timely prevention to avoid complications.

1 January 2025 in Neonatology: News, Opinions, Training
Verified
Journal Article
Open access
GTG.P. Tukabaev
G.P. Tukabaev
AMA.I. Makulova
A.I. Makulova
AТA.O. Тoporkova
A.O. Тoporkova
AFA.S. Filippov
A.S. Filippov
EIE.A. Ignatieva
E.A. Ignatieva
IAI.I. Afukov
I.I. Afukov
Новорожденный с тяжелой асфиксией и рабдомиолизом. Опыт лечения с применением различных методов заместительной почечной терапии и гемосорбции

1 January 2025 in Voprosy detskoj dietologii
Verified
Journal Article
Closed access
HSH.A. Sarkisyan
H.A. Sarkisyan
M9Moscow G.N.SPeransky Children’s City Clinical Hospital No 9
Moscow G.N.SPeransky Children’s City Clinical Hospital No 9
SSS.A. Sukhareva
S.A. Sukhareva
AKA.P. Khokhlova
A.P. Khokhlova
LML.M. Makarova
L.M. Makarova
PSP.V. Shumilov
P.V. Shumilov
Mitochondrial deoxyribonucleic acid depletion syndrome is a group of diseases with autosomal recessive inheritance associated with mutations in nuclear genes that encode components of the respiratory chain of "cellular energy stations". The disease is characterized by a decrease in the number of copies of the genetic material of mitochondria and, as a consequence, irreversible loss of their oxidative capacity with the accumulation of damaging metabolites. Currently, the pathology tends to spread and occurs with a frequency of 4.7 to 12.5 per 100,000 population, especially in some regions (in our case, a patient from the North Caucasus region is described). Heterogeneity of clinical manifestations is due to the variability of gene defects: myopathic, encephalomyopathic, and hepatocerebral forms of the disease are distinguished. Diseases associated with depletion of mitochondrial deoxyribonulinic acid manifest in the early neonatal period with critical metabolic disorders (hypoglycemia, lactatacidosis), clinically manifested by neurological deficit, liver failure and often lead to death. The development of liver cirrhosis in such patients requires liver transplantation, the efficacy of which is less than 50%. This article describes a clinical case of severe depletion syndrome associated with a homozygous mutation in the acceptor splice site, intron 7 of the MPV17 gene (OMIM #251880), (chr2:27532851T>C) resulting in a nucleotide substitution (NM_002437.5: c.462-2A>G), not previously described in the Russian-language literature. In contrast to most of the described observations, the first clinical manifestations in the presented patient were erased and included signs of lethargic baby syndrome. Despite symptomatic therapy, the patient required liver transplantation at the age of 4 months due to the development of cirrhosis. The article highlights the issues of clinic, diagnosis, and treatment of mitochondrial deoxyribonucleic acid depletion syndrome on the example of the observed child and patients previously described both in Russian and foreign literature. Key words: mitochondrial DNA depletion syndrome, hepatocerebral form, neonatal cholestasis, liver, liver failure, neurologic disorders, liver transplantation